Schuldesz, A.C.; Tudor, R.; Cornea, A.; Geni, D.N.; Lata, I.N.; Simu, M.
Effectiveness of Ocrelizumab on Disease Progression and Disability Status in Multiple Sclerosis Patients: A Two-Year Prospective Cohort Study. J. Clin. Med. 2025, 14, 553.
https://doi.org/10.3390/jcm14020553
AMA Style
Schuldesz AC, Tudor R, Cornea A, Geni DN, Lata IN, Simu M.
Effectiveness of Ocrelizumab on Disease Progression and Disability Status in Multiple Sclerosis Patients: A Two-Year Prospective Cohort Study. Journal of Clinical Medicine. 2025; 14(2):553.
https://doi.org/10.3390/jcm14020553
Chicago/Turabian Style
Schuldesz, Amanda Claudia, Raluca Tudor, Amalia Cornea, Dorina Nicola Geni, Irina Nicoleta Lata, and Mihaela Simu.
2025. "Effectiveness of Ocrelizumab on Disease Progression and Disability Status in Multiple Sclerosis Patients: A Two-Year Prospective Cohort Study" Journal of Clinical Medicine 14, no. 2: 553.
https://doi.org/10.3390/jcm14020553
APA Style
Schuldesz, A. C., Tudor, R., Cornea, A., Geni, D. N., Lata, I. N., & Simu, M.
(2025). Effectiveness of Ocrelizumab on Disease Progression and Disability Status in Multiple Sclerosis Patients: A Two-Year Prospective Cohort Study. Journal of Clinical Medicine, 14(2), 553.
https://doi.org/10.3390/jcm14020553
